hotspot -WSS

hotspot

author：entertainment 2025-09-30 22:10:35 - browse：8

insulin biosimilar — Last week, the FDA released a trio of guidelines clarifying the way they plan to evaluate devices that go through the 510(k) pathway. Jacquelyn Martin/AP

Five years after promising to fix a flawed regulatory pathway widely used by medical device manufacturers, the Food and Drug Administration has issued new guidelines to improve its so-called 510(k) program that has long been lambasted for letting risky devices fall through the cracks.

Most medical device companies do not have to test their products on people in order to secure clearance from the FDA — they simply have to show they’re “substantially equivalent” to devices already on the market, called “predicates.” This process is the 510(k) pathway, and accounts for the vast majority of new medical devices launched on the market each year. Devices cleared through this pathway include X-ray machines, muscle stimulators, and wheelchairs.

Last week, the FDA released a trio of guidelines clarifying the way it plans to evaluate devices that go through the 510(k) pathway. The agency is asking manufacturers to avoid predicate devices that were recalled due to a “design-related” issue or have “unmitigated” safety concerns. Manufacturers should submit flow charts explaining why they chose their predicate device. If they have to choose one with a recall history or safety issues, they should explain how the new device addresses those problems. The FDA may also ask the manufacturer for clinical data in this case.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： STAT Readout Newsletter: Biotech news today

WSS

Is there really a nursing shortage in the U.S.?

The biotech scorecard for Q4: 16 stock

STAT Readout: Friday, Oct. 20 biotech updates

IVG is promising — but it won’t replace IVF quite yet

STAT Summit: How researchers deal with rejection

European officials brace for rough respiratory virus season

entertainment

hotspot

knowledge

23andMe had bad news about my health. I wish a person had delivered it

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Wildfire smoke exposes gaps in outdoor worker protections

How AI can help patients find reliable information about doctors

At least 13 dead in Texas as scorching temps continue

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

Trump demands the U.S. pay no more for drugs than other countries … again

How AI can help patients find reliable information about doctors

Heart attack and stroke risk calculators need revising

Some top drug companies are starting to take action on climate

Wikipedia

Some top drug companies are starting to take action on climate

Study on Amgen’s bispecific immunotherapy produces positive data

Flu, Covid vaccination rates decline, new survey data show

Roche acquires Telavant from Roivant, adding experimental IBD treatment

STAT Summit: The economic case for universal basic health care

Results on Novartis prostate cancer therapy could expand its use

focus

hotspot

explore

focus